Wells Fargo’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40
Closed -$1.16K 7375
2025
Q4
$1.16K Sell
40
-1,200
-97% -$22.8K ﹤0.01% 6272
2025
Q3
$9.62K Buy
1,240
+319
+35% +$2.39K ﹤0.01% 5949
2025
Q2
$6.81K Sell
921
-2,219
-71% -$19.5K ﹤0.01% 6028
2025
Q1
$27K Buy
3,140
+441
+16% +$6.8K ﹤0.01% 5605
2024
Q4
$96.5K Buy
2,699
+774
+40% +$40K ﹤0.01% 5223
2024
Q3
$90.9K Buy
1,925
+34
+2% +$1.5K ﹤0.01% 5075
2024
Q2
$95K Buy
1,891
+386
+26% +$27.9K ﹤0.01% 4969
2024
Q1
$169K Buy
1,505
+272
+22% +$27K ﹤0.01% 4569
2023
Q4
$71.5K Buy
1,233
+312
+34% +$12.6K ﹤0.01% 5105
2023
Q3
$29.2K Sell
921
-3,195
-78% -$152K ﹤0.01% 5441
2023
Q2
$339K Buy
4,116
+225
+6% +$32.9K ﹤0.01% 4231
2023
Q1
$400K Buy
+3,891
New +$546K ﹤0.01% 4000
2022
Q4
Sell
-62
Closed -$10K 7662
2022
Q3
$10K Buy
62
+16
+35% +$2.6K ﹤0.01% 5686
2022
Q2
$5K Sell
46
-663
-94% -$62.4K ﹤0.01% 6009
2022
Q1
$71K Sell
709
-961
-58% -$112K ﹤0.01% 5482
2021
Q4
$259K Buy
1,670
+1,456
+680% +$283K ﹤0.01% 5116
2021
Q3
$50K Buy
214
+212
+10,600% +$61.9K ﹤0.01% 5628
2021
Q2
$1K Sell
2
-852
-100% -$323K ﹤0.01% 6696
2021
Q1
$345K Sell
854
-4,068
-83% -$1.97M ﹤0.01% 4886
2020
Q4
$3.27M Sell
4,922
-245
-5% -$136K ﹤0.01% 3111
2020
Q3
$2.4M Buy
5,167
+435
+9% +$220K ﹤0.01% 3167
2020
Q2
$2.77M Buy
4,732
+1,675
+55% +$572K ﹤0.01% 3008
2020
Q1
$446K Buy
3,057
+1,401
+85% +$245K ﹤0.01% 4122
2019
Q4
$237K Sell
1,656
-337
-17% -$24.6K ﹤0.01% 4844
2019
Q3
$78K Buy
1,993
+1,802
+943% +$131K ﹤0.01% 5419
2019
Q2
$19K Sell
191
-38
-17% -$4.48K ﹤0.01% 5796
2019
Q1
$30K Sell
229
-1
-0.4% -$126 ﹤0.01% 5432
2018
Q4
$23K Sell
230
-437
-66% -$69.1K ﹤0.01% 5745
2018
Q3
$166K Buy
667
+4
+0.6% +$1.34K ﹤0.01% 5098
2018
Q2
$297K Buy
663
+439
+196% +$193K ﹤0.01% 4809
2018
Q1
$88K Buy
224
+38
+20% +$15K ﹤0.01% 5360
2017
Q4
$76K Buy
186
+172
+1,229% +$75K ﹤0.01% 5413
2017
Q3
$6K Buy
+14
New +$5.52K ﹤0.01% 5984

Other funds holding MRSN